Literature DB >> 12632070

O(2) extraction is a key parameter determining the oxygenation status of malignant tumors and normal tissues.

Peter Vaupel1, Oliver Thews, Debra K Kelleher, Moritz A Konerding.   

Abstract

The aim of this study was to assess pivotal factors determining the oxygenation status of malignant tumors, and, for comparison, of normal tissues. For this purpose, microvascular patterns, blood flow data, O2 consumption rates and O2 extractions were correlated to the median pO2 values of isografted rodent and xenografted human tumors, and of various normal tissues. No correlations were found between median pO2 values and vascular patterns, O2 consumption rate or blood flow rate. When O2 extraction, however, was considered (a comprehensive parameter which encompasses all of the above factors), a strong inverse correlation was found between this parameter and the median pO2 values, both for malignant tumors (r2=0.917) and normal tissues (r2=0.959). At similar O2 extraction values, the median pO2 values in the solid tumors were substantially lower than those in normal tissues, a finding which most probably reflects the chaotic microcirculation found in tumors, the loss of flow regulation which in normal tissues meets the metabolic demands of the cells, and in some cases, tumor-associated anemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632070

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.

Authors:  P D Hardt; S Mazurek; M Toepler; P Schlierbach; R G Bretzel; E Eigenbrodt; H U Kloer
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

2.  Inhibition of Tumor Growth of Human Hepatocellular Carcinoma HepG2 Cells in a Nude Mouse Xenograft Model by the Total Flavonoids from Arachniodes exilis.

Authors:  Huimin Li; Dengzhao Jiang; Lei Zhang; Jiazhong Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-19       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.